The global market for mRNA Synthesis Raw Materials was valued at US$ 1736 million in the year 2024 and is projected to reach a revised size of US$ 2401 million by 2031, growing at a CAGR of 5.5% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on mRNA Synthesis Raw Materials competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
mRNA Synthesis Raw Materials are essential chemical and biological components for in vitro transcription (IVT) to produce messenger RNA, including cap analogs (e.g., CleanCap), nucleotide triphosphates (NTPs), DNA templates, RNA polymerases (e.g., T7/T3), and modified nucleosides (e.g., pseudouridine 蠄). Their quality critically impacts mRNA vaccines/therapeutics鈥� efficacy, stability, and immunogenicity, requiring stringent standards like high purity (鈮�99%) and low endotoxin (<0.05EU/mg). Applications span infectious disease prevention (e.g., COVID-19 vaccines), cancer immunotherapy, and protein replacement therapies. Suppliers must provide cGMP-grade materials with Certificates of Analysis (CoA) and stability data. Key challenges include patent barriers (e.g., modified nucleosides) and cold-chain logistics, yet demand grows with mRNA technology advancements.
North American market for mRNA Synthesis Raw Materials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for mRNA Synthesis Raw Materials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of mRNA Synthesis Raw Materials include Areterna LLC, Thermo Fisher Scientific, Roche, Promega, Jena Bioscience, Merck, Yeasen Biotechnology, TriLink BioTechnologies (Maravai LifeSciences), Creative Biogene, HONGENE, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Synthesis Raw Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Synthesis Raw Materials.
The mRNA Synthesis Raw Materials market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Synthesis Raw Materials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Synthesis Raw Materials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Areterna LLC
Thermo Fisher Scientific
Roche
Promega
Jena Bioscience
Merck
Yeasen Biotechnology
TriLink BioTechnologies (Maravai LifeSciences)
Creative Biogene
HONGENE
Danaher
BioNTech
Moderna
Segment by Type
RNA Polymerase
Nucleotides
Linear DNA Template
Others
Segment by Application
Vaccine Production
Drug Discovery
Others
Production by Region
North America
Europe
China
Japan
India
Southeast Asia
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Synthesis Raw Materials manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of mRNA Synthesis Raw Materials by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of mRNA Synthesis Raw Materials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 mRNA Synthesis Raw Materials Market Overview
1.1 Product Definition
1.2 mRNA Synthesis Raw Materials by Type
1.2.1 Global mRNA Synthesis Raw Materials Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 RNA Polymerase
1.2.3 Nucleotides
1.2.4 Linear DNA Template
1.2.5 Others
1.3 mRNA Synthesis Raw Materials by Application
1.3.1 Global mRNA Synthesis Raw Materials Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Vaccine Production
1.3.3 Drug Discovery
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global mRNA Synthesis Raw Materials Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global mRNA Synthesis Raw Materials Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global mRNA Synthesis Raw Materials Production Estimates and Forecasts (2020-2031)
1.4.4 Global mRNA Synthesis Raw Materials Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global mRNA Synthesis Raw Materials Production Market Share by Manufacturers (2020-2025)
2.2 Global mRNA Synthesis Raw Materials Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of mRNA Synthesis Raw Materials, Industry Ranking, 2023 VS 2024
2.4 Global mRNA Synthesis Raw Materials Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global mRNA Synthesis Raw Materials Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of mRNA Synthesis Raw Materials, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of mRNA Synthesis Raw Materials, Product Offered and Application
2.8 Global Key Manufacturers of mRNA Synthesis Raw Materials, Date of Enter into This Industry
2.9 mRNA Synthesis Raw Materials Market Competitive Situation and Trends
2.9.1 mRNA Synthesis Raw Materials Market Concentration Rate
2.9.2 Global 5 and 10 Largest mRNA Synthesis Raw Materials Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 mRNA Synthesis Raw Materials Production by Region
3.1 Global mRNA Synthesis Raw Materials Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global mRNA Synthesis Raw Materials Production Value by Region (2020-2031)
3.2.1 Global mRNA Synthesis Raw Materials Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of mRNA Synthesis Raw Materials by Region (2026-2031)
3.3 Global mRNA Synthesis Raw Materials Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global mRNA Synthesis Raw Materials Production Volume by Region (2020-2031)
3.4.1 Global mRNA Synthesis Raw Materials Production by Region (2020-2025)
3.4.2 Global Forecasted Production of mRNA Synthesis Raw Materials by Region (2026-2031)
3.5 Global mRNA Synthesis Raw Materials Market Price Analysis by Region (2020-2025)
3.6 Global mRNA Synthesis Raw Materials Production and Value, Year-over-Year Growth
3.6.1 North America mRNA Synthesis Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe mRNA Synthesis Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.3 China mRNA Synthesis Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan mRNA Synthesis Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.5 India mRNA Synthesis Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.6 Southeast Asia mRNA Synthesis Raw Materials Production Value Estimates and Forecasts (2020-2031)
4 mRNA Synthesis Raw Materials Consumption by Region
4.1 Global mRNA Synthesis Raw Materials Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global mRNA Synthesis Raw Materials Consumption by Region (2020-2031)
4.2.1 Global mRNA Synthesis Raw Materials Consumption by Region (2020-2025)
4.2.2 Global mRNA Synthesis Raw Materials Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America mRNA Synthesis Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America mRNA Synthesis Raw Materials Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe mRNA Synthesis Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe mRNA Synthesis Raw Materials Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific mRNA Synthesis Raw Materials Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific mRNA Synthesis Raw Materials Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa mRNA Synthesis Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa mRNA Synthesis Raw Materials Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global mRNA Synthesis Raw Materials Production by Type (2020-2031)
5.1.1 Global mRNA Synthesis Raw Materials Production by Type (2020-2025)
5.1.2 Global mRNA Synthesis Raw Materials Production by Type (2026-2031)
5.1.3 Global mRNA Synthesis Raw Materials Production Market Share by Type (2020-2031)
5.2 Global mRNA Synthesis Raw Materials Production Value by Type (2020-2031)
5.2.1 Global mRNA Synthesis Raw Materials Production Value by Type (2020-2025)
5.2.2 Global mRNA Synthesis Raw Materials Production Value by Type (2026-2031)
5.2.3 Global mRNA Synthesis Raw Materials Production Value Market Share by Type (2020-2031)
5.3 Global mRNA Synthesis Raw Materials Price by Type (2020-2031)
6 Segment by Application
6.1 Global mRNA Synthesis Raw Materials Production by Application (2020-2031)
6.1.1 Global mRNA Synthesis Raw Materials Production by Application (2020-2025)
6.1.2 Global mRNA Synthesis Raw Materials Production by Application (2026-2031)
6.1.3 Global mRNA Synthesis Raw Materials Production Market Share by Application (2020-2031)
6.2 Global mRNA Synthesis Raw Materials Production Value by Application (2020-2031)
6.2.1 Global mRNA Synthesis Raw Materials Production Value by Application (2020-2025)
6.2.2 Global mRNA Synthesis Raw Materials Production Value by Application (2026-2031)
6.2.3 Global mRNA Synthesis Raw Materials Production Value Market Share by Application (2020-2031)
6.3 Global mRNA Synthesis Raw Materials Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Areterna LLC
7.1.1 Areterna LLC mRNA Synthesis Raw Materials Company Information
7.1.2 Areterna LLC mRNA Synthesis Raw Materials Product Portfolio
7.1.3 Areterna LLC mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Areterna LLC Main Business and Markets Served
7.1.5 Areterna LLC Recent Developments/Updates
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific mRNA Synthesis Raw Materials Company Information
7.2.2 Thermo Fisher Scientific mRNA Synthesis Raw Materials Product Portfolio
7.2.3 Thermo Fisher Scientific mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Thermo Fisher Scientific Main Business and Markets Served
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.3 Roche
7.3.1 Roche mRNA Synthesis Raw Materials Company Information
7.3.2 Roche mRNA Synthesis Raw Materials Product Portfolio
7.3.3 Roche mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Roche Main Business and Markets Served
7.3.5 Roche Recent Developments/Updates
7.4 Promega
7.4.1 Promega mRNA Synthesis Raw Materials Company Information
7.4.2 Promega mRNA Synthesis Raw Materials Product Portfolio
7.4.3 Promega mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Promega Main Business and Markets Served
7.4.5 Promega Recent Developments/Updates
7.5 Jena Bioscience
7.5.1 Jena Bioscience mRNA Synthesis Raw Materials Company Information
7.5.2 Jena Bioscience mRNA Synthesis Raw Materials Product Portfolio
7.5.3 Jena Bioscience mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Jena Bioscience Main Business and Markets Served
7.5.5 Jena Bioscience Recent Developments/Updates
7.6 Merck
7.6.1 Merck mRNA Synthesis Raw Materials Company Information
7.6.2 Merck mRNA Synthesis Raw Materials Product Portfolio
7.6.3 Merck mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Merck Main Business and Markets Served
7.6.5 Merck Recent Developments/Updates
7.7 Yeasen Biotechnology
7.7.1 Yeasen Biotechnology mRNA Synthesis Raw Materials Company Information
7.7.2 Yeasen Biotechnology mRNA Synthesis Raw Materials Product Portfolio
7.7.3 Yeasen Biotechnology mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Yeasen Biotechnology Main Business and Markets Served
7.7.5 Yeasen Biotechnology Recent Developments/Updates
7.8 TriLink BioTechnologies (Maravai LifeSciences)
7.8.1 TriLink BioTechnologies (Maravai LifeSciences) mRNA Synthesis Raw Materials Company Information
7.8.2 TriLink BioTechnologies (Maravai LifeSciences) mRNA Synthesis Raw Materials Product Portfolio
7.8.3 TriLink BioTechnologies (Maravai LifeSciences) mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.8.4 TriLink BioTechnologies (Maravai LifeSciences) Main Business and Markets Served
7.8.5 TriLink BioTechnologies (Maravai LifeSciences) Recent Developments/Updates
7.9 Creative Biogene
7.9.1 Creative Biogene mRNA Synthesis Raw Materials Company Information
7.9.2 Creative Biogene mRNA Synthesis Raw Materials Product Portfolio
7.9.3 Creative Biogene mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Creative Biogene Main Business and Markets Served
7.9.5 Creative Biogene Recent Developments/Updates
7.10 HONGENE
7.10.1 HONGENE mRNA Synthesis Raw Materials Company Information
7.10.2 HONGENE mRNA Synthesis Raw Materials Product Portfolio
7.10.3 HONGENE mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.10.4 HONGENE Main Business and Markets Served
7.10.5 HONGENE Recent Developments/Updates
7.11 Danaher
7.11.1 Danaher mRNA Synthesis Raw Materials Company Information
7.11.2 Danaher mRNA Synthesis Raw Materials Product Portfolio
7.11.3 Danaher mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Danaher Main Business and Markets Served
7.11.5 Danaher Recent Developments/Updates
7.12 BioNTech
7.12.1 BioNTech mRNA Synthesis Raw Materials Company Information
7.12.2 BioNTech mRNA Synthesis Raw Materials Product Portfolio
7.12.3 BioNTech mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.12.4 BioNTech Main Business and Markets Served
7.12.5 BioNTech Recent Developments/Updates
7.13 Moderna
7.13.1 Moderna mRNA Synthesis Raw Materials Company Information
7.13.2 Moderna mRNA Synthesis Raw Materials Product Portfolio
7.13.3 Moderna mRNA Synthesis Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Moderna Main Business and Markets Served
7.13.5 Moderna Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 mRNA Synthesis Raw Materials Industry Chain Analysis
8.2 mRNA Synthesis Raw Materials Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 mRNA Synthesis Raw Materials Production Mode & Process Analysis
8.4 mRNA Synthesis Raw Materials Sales and Marketing
8.4.1 mRNA Synthesis Raw Materials Sales Channels
8.4.2 mRNA Synthesis Raw Materials Distributors
8.5 mRNA Synthesis Raw Materials Customer Analysis
9 mRNA Synthesis Raw Materials Market Dynamics
9.1 mRNA Synthesis Raw Materials Industry Trends
9.2 mRNA Synthesis Raw Materials Market Drivers
9.3 mRNA Synthesis Raw Materials Market Challenges
9.4 mRNA Synthesis Raw Materials Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Areterna LLC
Thermo Fisher Scientific
Roche
Promega
Jena Bioscience
Merck
Yeasen Biotechnology
TriLink BioTechnologies (Maravai LifeSciences)
Creative Biogene
HONGENE
Danaher
BioNTech
Moderna
听
听
*If Applicable.
